Indraprastha Medical (NSE:INDRAMEDCO) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDRAMEDCO Indraprastha Medical Corp Ltd NSE:INDRAMEDCO
86 GF Score
Price ₹352.35
GF Value ₹426.17
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Indraprastha Medical FFO?

FFO (Funds from operations) only applies to REITs.

NSE:INDRAMEDCO
86GF Score
Indraprastha Medical Corp Ltd NSE:INDRAMEDCO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Indraprastha Medical (NSE:INDRAMEDCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued. The current stock price of ₹352.35 is trading 17.3% below its estimated GF Value™ of ₹426.17. GuruFocus considers Indraprastha Medical to be Modestly Undervalued.

Key valuation signals for NSE:INDRAMEDCO:

  • FFO:
  • GF Value™: ₹426.17 vs. price of ₹352.35 (17.3% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the NSE:INDRAMEDCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indraprastha Medical Business Description

Other Exchanges 532150:India
Address Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
86GF Score

Get the complete analysis for NSE:INDRAMEDCO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹352.35
Price
₹426.17
GF Value